triamterene and hydrochlorothiazide
Generic: triamterene and hydrochlorothiazide
Labeler: advagen pharma ltdDrug Facts
Product Profile
Brand Name
triamterene and hydrochlorothiazide
Generic Name
triamterene and hydrochlorothiazide
Labeler
advagen pharma ltd
Dosage Form
TABLET
Routes
Active Ingredients
hydrochlorothiazide 50 mg/1, triamterene 75 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72888-095
Product ID
72888-095_47ca5405-6d4e-755a-e063-6394a90acbfc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216211
Listing Expiration
2027-12-31
Marketing Start
2022-02-23
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72888095
Hyphenated Format
72888-095
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
triamterene and hydrochlorothiazide (source: ndc)
Generic Name
triamterene and hydrochlorothiazide (source: ndc)
Application Number
ANDA216211 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
- 75 mg/1
Packaging
- 1000 TABLET in 1 BOTTLE (72888-095-00)
- 100 TABLET in 1 BOTTLE (72888-095-01)
- 500 TABLET in 1 BOTTLE (72888-095-05)
- 30 TABLET in 1 BOTTLE (72888-095-30)
Packages (4)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47ca5405-6d4e-755a-e063-6394a90acbfc", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "upc": ["0372888094014", "0372888094007", "0372888095301", "0372888094052", "0372888095011", "0372888094304", "0372888095059", "0372888095004"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["310812", "310818"], "spl_set_id": ["a5525a2a-d2c7-411b-9ffc-0cc4fe77f7c7"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (72888-095-00)", "package_ndc": "72888-095-00", "marketing_start_date": "20230202"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (72888-095-01)", "package_ndc": "72888-095-01", "marketing_start_date": "20230202"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (72888-095-05)", "package_ndc": "72888-095-05", "marketing_start_date": "20230202"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (72888-095-30)", "package_ndc": "72888-095-30", "marketing_start_date": "20230202"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "72888-095_47ca5405-6d4e-755a-e063-6394a90acbfc", "dosage_form": "TABLET", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "72888-095", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "50 mg/1"}, {"name": "TRIAMTERENE", "strength": "75 mg/1"}], "application_number": "ANDA216211", "marketing_category": "ANDA", "marketing_start_date": "20220223", "listing_expiration_date": "20271231"}